Size | Price | Stock | Qty |
---|---|---|---|
1g |
|
||
Other Sizes |
|
Additional Infomation |
Dihydrostreptomycin Sulfate is a semi-synthetic aminoglycoside antibiotic with bactericidal properties. Dihydrostreptomycin sulfate inhibits protein synthesis by binding to the 30S ribosomal subunit. This antibiotic is active against most gram-positive and gram-negative organisms and is used in the treatment of tuberculosis and tulemia.
A semi-synthetic aminoglycoside antibiotic that is used in the treatment of TUBERCULOSIS. See also: Dihydrostreptomycin (has active moiety); Dihydrostreptomycin Sulfate; Penicillin G Procaine (component of). |
---|
Molecular Formula |
C42H88N14O36S3
|
---|---|
Molecular Weight |
1460.41
|
CAS # |
5490-27-7
|
PubChem CID |
21653
|
Appearance |
White to off-white solid powder
|
Boiling Point |
954.5ºC at 760 mmHg
|
Flash Point |
531.1ºC
|
Hydrogen Bond Donor Count |
32
|
Hydrogen Bond Acceptor Count |
42
|
Rotatable Bond Count |
18
|
Heavy Atom Count |
95
|
Complexity |
993
|
Defined Atom Stereocenter Count |
30
|
SMILES |
S(=O)(=O)(O[H])O[H].S(=O)(=O)(O[H])O[H].S(=O)(=O)(O[H])O[H].O([C@@]1([H])[C@@]([H])([C@]([H])([C@@]([H])([C@]([H])([C@]1([H])/N=C(\N([H])[H])/N([H])[H])O[H])/N=C(\N([H])[H])/N([H])[H])O[H])O[H])[C@@]1([H])[C@@]([H])([C@@](C([H])([H])O[H])([C@]([H])(C([H])([H])[H])O1)O[H])O[C@@]1([H])[C@]([H])([C@@]([H])([C@]([H])([C@]([H])(C([H])([H])O[H])O1)O[H])O[H])N([H])C([H])([H])[H].O([C@@]1([H])[C@@]([H])([C@]([H])([C@@]([H])([C@]([H])([C@]1([H])/N=C(\N([H])[H])/N([H])[H])O[H])/N=C(\N([H])[H])/N([H])[H])O[H])O[H])[C@@]1([H])[C@@]([H])([C@@](C([H])([H])O[H])([C@]([H])(C([H])([H])[H])O1)O[H])O[C@@]1([H])[C@]([H])([C@@]([H])([C@]([H])([C@]([H])(C([H])([H])O[H])O1)O[H])O[H])N([H])C([H])([H])[H]
|
Synonyms |
AI3 50133; AI3-50133; Dihydrostreptomycin Sulfate
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
H2O : ~250 mg/mL (~342.13 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (136.85 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
 (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 0.6847 mL | 3.4237 mL | 6.8474 mL | |
5 mM | 0.1369 mL | 0.6847 mL | 1.3695 mL | |
10 mM | 0.0685 mL | 0.3424 mL | 0.6847 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.